"61744"^^ . . . . . . . . . . . . "61164"^^ . "1"^^ . . "V\u0161echny indikace:\nMetaanal\u00FDza 14\u00A0klinick\u00FDch hodnocen\u00ED s\u00A0daty od v\u00EDce ne\u017E 4700\u00A0pacient\u016F l\u00E9\u010Den\u00FDch kapecitabinem v\u00A0monoterapii nebo kapecitabinem v\u00A0kombinaci s\u00A0r\u016Fzn\u00FDmi re\u017Eimy chemoterapie v\u00A0mnoh\u00FDch indikac\u00EDch (karcinom tlust\u00E9ho st\u0159eva, kolorekt\u00E1ln\u00ED karcinom, karcinom prsu) uk\u00E1zala, \u017Ee pacienti l\u00E9\u010Den\u00ED kapecitabinem, u nich\u017E se vyvinul syndrom ruka-noha, m\u011Bli del\u0161\u00ED celkov\u00E9 p\u0159e\u017Eit\u00ED ve srovn\u00E1n\u00ED s\u00A0pacienty, u kter\u00FDch ke vzniku syndromu ruka-noha nedo\u0161lo: medi\u00E1n celkov\u00E9ho p\u0159e\u017Eit\u00ED 1100\u00A0dn\u016F (95% CI 1007; 1200) oproti 691\u00A0dn\u016Fm (95% CI 638; 754) s\u00A0pom\u011Brem rizik 0,61 (95% CI 0,56; 0,66)."@cs .